What is the sweat test and why is it used for cystic fibrosis? 

The sweat test is a non-invasive diagnostic procedure that measures the concentration of chloride (salt) in a person’s sweat. It is widely considered the “gold standard” for confirming a diagnosis of cystic fibrosis because it directly measures the physical impact of the faulty CFTR protein on the body. While newborn screening and genetic tests provide important clues, the sweat test offers definitive physiological evidence of the condition. By assessing how effectively the sweat glands reabsorb salt, healthcare professionals can accurately identify whether a patient has the characteristic salt imbalance that defines cystic fibrosis. 

What We’ll Discuss in This Article 

• The biological reason why people with cystic fibrosis have salty sweat. 

• A step-by-step guide to how the sweat test is performed. 

• Understanding the chloride levels and what they mean for diagnosis. 

• Why the sweat test is used alongside newborn screening and genetic tests. 

• The safety and reliability of the test for infants and adults. 

• How the results guide the next steps in clinical management. 

The biology of salty sweat in cystic fibrosis 

The primary reason the sweat test is used is that cystic fibrosis affects the body’s ability to transport salt and water across cell membranes. In a healthy body, the CFTR protein acts as a channel that helps move chloride to the surface of the skin to produce sweat, and then reabsorbs much of that salt back into the body before the sweat leaves the skin. According to the NHS, in people with cystic fibrosis, the CFTR protein does not work correctly, meaning salt is not reabsorbed and remains in high concentrations on the skin. This biological error is what makes the skin of an individual with the condition taste unusually salty. 

How the sweat test is performed 

The sweat test is a simple, painless procedure that typically takes about an hour to complete. It does not involve any needles or injections. Instead, it uses a process called iontophoresis to stimulate the sweat glands in a small area of the skin, usually on the forearm or the leg. 

1. Stimulation: A healthcare professional applies a sweat-inducing chemical called pilocarpine to the skin. Two electrodes are placed over the area, and a very weak electrical current is passed through them for about five minutes. This helps the chemical penetrate the sweat glands. 

2. Collection: The skin is cleaned, and a collection device either a piece of filter paper or a small plastic coil is taped to the site. The area is wrapped in plastic to keep it warm and encourage sweating. 

3. Analysis: After approximately 30 minutes, the collection device is removed and sent to a laboratory where the concentration of chloride in the sweat is measured using precise biochemical equipment. 

Interpreting the sweat test results 

The results of a sweat test are measured in millimoles per litre (mmol/L) of chloride. These results are categorised into three main ranges that help clinicians determine the likelihood of a cystic fibrosis diagnosis. NICE guidance provides specific thresholds for interpreting these results in both children and adults. 

• Normal (30 mmol/L or less): This result suggests that cystic fibrosis is very unlikely. The sweat glands are functioning correctly by reabsorbing salt. 

• Borderline (30 to 59 mmol/L): This result is inconclusive. It may occur in individuals with “atypical” or milder forms of the condition. In these cases, the test is usually repeated, and detailed genetic testing is required. 

• Positive (60 mmol/L or higher): A result in this range, especially when combined with clinical symptoms or a positive newborn screen, confirms a diagnosis of cystic fibrosis. 

Why the sweat test is essential for diagnosis 

While genetic testing can identify many mutations, there are over 2,000 variations of the cystic fibrosis gene, and a standard genetic screen may miss rarer types. The sweat test is essential because it measures the function of the CFTR protein rather than just the presence of a gene. Even if only one genetic mutation is found, a positive sweat test proves that the protein is not working correctly, allowing for a clinical diagnosis. This is particularly important in the UK, where newborn screening identifies “at-risk” babies who then require the sweat test to confirm whether the high IRT levels in their blood were actually caused by the condition. 

Safety, reliability, and age considerations 

The sweat test is safe for individuals of almost any age. In the UK, it is commonly performed on babies once they are at least two weeks old and weigh enough to produce a sufficient amount of sweat (usually over 3kg). The Royal Brompton & Harefield hospitals note that if a baby is too small or dehydrated, they may not produce enough sweat for a valid sample, and the test will need to be rescheduled. For adults, the test is just as reliable and is a key tool in investigating late-onset symptoms like recurring pancreatitis or unexplained lung damage. 

Test Aspect	Details
Duration	Approximately 45 to 60 minutes.
Pain Level	Painless (slight tingling sensation).
Accuracy	Extremely high (the gold standard).
Preparation	Avoid lotions or creams on the skin for 24 hours.
Result Timing	Usually available the same or next day.

Conclusion 

The sweat test remains the most important clinical tool for diagnosing cystic fibrosis by measuring the characteristic high levels of salt in a patient’s sweat. It is a safe, painless, and highly reliable procedure that provides definitive evidence of the condition’s impact on the body’s salt-transport mechanisms. Whether used to confirm a newborn screening result or to investigate symptoms in an adult, the sweat test ensures that patients receive an accurate diagnosis and can begin the specialist care they need. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides a medically accurate explanation of the cystic fibrosis sweat test, strictly following the clinical protocols used by the NHS and NICE. The content is developed by a professional medical writing team and has been reviewed by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in internal medicine and emergency care. It is intended to help patients and families understand the diagnostic process and the importance of physiological testing in managing cystic fibrosis.